BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2697544)

  • 1. [A double-blind clinical trial--the effects of pantethine on serum lipids in patients with hyperlipidemia].
    Lu ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug; 17(4):221-3. PubMed ID: 2697544
    [No Abstract]   [Full Text] [Related]  

  • 2. Pantethine improves the lipid abnormalities of chronic hemodialysis patients: results of a multicenter clinical trial.
    Donati C; Barbi G; Cairo G; Prati GF; Degli Esposti E
    Clin Nephrol; 1986 Feb; 25(2):70-4. PubMed ID: 3516477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of the lipotropic activity of the preparation Fosfolip].
    Ligas B; Proietti C; Chiti D
    Minerva Med; 1983 Apr; 74(14-15):835-8. PubMed ID: 6340000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of long-term treatment with pantethine in patients with dyslipidemia.
    Arsenio L; Bodria P; Magnati G; Strata A; Trovato R
    Clin Ther; 1986; 8(5):537-45. PubMed ID: 3094958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of pantethine in dyslipidemia of chronic uremic patients under dialysis treatment].
    Bergesio F; Ciuti R; Innocenti D; Galli GA; Frizzi V
    G Clin Med; 1985; 66(11-12):433-40. PubMed ID: 3835087
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical use of pantethine by parenteral route in the treatment of hyperlipidemia].
    Arsenio L; Bodria P; Bossi S; Lateana M; Strata A
    Acta Biomed Ateneo Parmense; 1987; 58(5-6):143-52. PubMed ID: 2970754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantethine versus fenofibrate in the treatment of type II hyperlipoproteinemia.
    Postiglione A; Rubba P; Cicerano U; Chierchia I; Mancini M
    Monogr Atheroscler; 1985; 13():145-8. PubMed ID: 3911056
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of pantethine on blood lipids].
    Giannini SD; Forti N; Di Rienzo F; Campanari JC; Ziliotto EE
    Arq Bras Cardiol; 1986 Apr; 46(4):283-9. PubMed ID: 3548666
    [No Abstract]   [Full Text] [Related]  

  • 9. [Double-blind evaluation of the antidyslipidemic effect of a combined phosphorylcholine and pantetheine product].
    Ligas B; Proietti C; Chiti D
    Clin Ter; 1985 Jan; 112(2):149-54. PubMed ID: 4017457
    [No Abstract]   [Full Text] [Related]  

  • 10. Lowering effect of pantethine on plasma beta-thromboglobulin and lipids in diabetes mellitus.
    Eto M; Watanabe K; Chonan N; Ishii K
    Artery; 1987; 15(1):1-12. PubMed ID: 2963604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children.
    Bertolini S; Donati C; Elicio N; Daga A; Cuzzolaro S; Marcenaro A; Saturnino M; Balestreri R
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):630-7. PubMed ID: 3098691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment.
    Gensini GF; Prisco D; Rogasi PG; Matucci M; Neri Serneri GG
    Int J Clin Pharmacol Res; 1985; 5(5):309-18. PubMed ID: 4066081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of coenzyme A vs pantethine for the treatment of patients with hyperlipidemia: A randomized, double-blind, multicenter study.
    Chen YQ; Zhao SP; Zhao YH
    J Clin Lipidol; 2015; 9(5):692-7. PubMed ID: 26350816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pantethine on different models of experimental hyperlipidemia in rodents: a comparison with clofibrate.
    Farina R; Lovati MR; Raucci G; Sirtori CR
    Pharmacol Res Commun; 1982 Jun; 14(6):499-510. PubMed ID: 7122675
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the cholesterol-lowering effectiveness of pantethine in women in perimenopausal age].
    Binaghi P; Cellina G; Lo Cicero G; Bruschi F; Porcaro E; Penotti M
    Minerva Med; 1990 Jun; 81(6):475-9. PubMed ID: 2359503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic efficacy of pantothenic acid preparations in ischemic heart disease patients].
    Borets VM; Lis MA; Pyrochkin VM; Kishkovich VP; Butkevich ND
    Vopr Pitan; 1987; (2):15-7. PubMed ID: 3590676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of activated charcoal on hyperlipidaemia. A double-blind prospective trial.
    Hoekstra JB; Erkelens DW
    Neth J Med; 1988 Dec; 33(5-6):209-16. PubMed ID: 3065658
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of hyperlipidemia. Clinical experience with clinofibrate].
    Avellone G; Di Garbo V; Strano A
    Clin Ter; 1989 Apr; 129(1):25-9. PubMed ID: 2525449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Double-blind trial on the trophic and anti-atherosclerotic preventive efficacy of a phosphorylcholine-pantetheine combination].
    Proietti C; Imperiale A; Chiti D
    Clin Ter; 1985 Feb; 112(4):333-7. PubMed ID: 4017462
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical study on the anti-lipidemia and anti-steatosis effectiveness of the pantetheine-phosphorylcholine pharmacologic combination].
    Coto V; Oliviero U; Lucariello A; Cerini R; Cocozza M; Cacciatore L; Porfido FA; Lingetti M; Scarpellino F; Talarico M
    Clin Ter; 1986 Sep; 118(6):415-21. PubMed ID: 3780171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.